当前位置:首页 - 行情中心 - 昆药集团(600422) - 财务分析

昆药集团

(600422)

  

流通市值:72.06亿  总市值:72.06亿
流通股本:7.57亿   总股本:7.57亿

昆药集团(600422)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润-1.45亿元,每股收益-0.19元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益679754.73万元,未分配利润359292.51万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产1121540.33万元,负债441785.60万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入836,158,258.46,575,214,133.554,751,206,077.583,351,347,279.45
营业总成本1,005,316,275.736,335,560,770.884,530,354,855.673,100,213,351.06
其他经营收益
营业利润-134,001,212.92448,507,950.06379,298,300.11299,803,982.41
利润总额-138,290,887.81473,557,838.67378,421,050.69298,940,268.97
净利润-144,847,651.79419,052,861.68323,404,751.99249,920,820.76
每股收益
其他综合收益-1,449,310.54-12,037,693.6229,191.861,987,515.85
综合收益总额-146,296,962.33407,015,168.06323,433,943.85251,908,336.61
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计7,123,806,677.487,723,739,881.557,961,178,600.978,635,256,590.09
非流动资产:
非流动资产合计4,091,596,597.774,049,824,526.94,044,953,367.664,022,532,237.03
资产总计11,215,403,275.2511,773,564,408.4512,006,131,968.6312,657,788,827.12
流动负债:
流动负债合计3,411,923,430.743,825,689,164.74,123,871,040.54,861,855,581.8
非流动负债:
非流动负债合计1,005,932,579.481,006,470,657.091,026,542,116.531,024,850,060.87
负债合计4,417,856,010.224,832,159,821.795,150,413,157.035,886,705,642.67
所有者权益(或股东权益):
归属于母公司股东权益合计5,221,546,495.855,362,259,636.545,308,840,393.435,226,959,645.61
股东权益合计6,797,547,265.036,941,404,586.666,855,718,811.66,771,083,184.45
负债和股东权益合计11,215,403,275.2511,773,564,408.4512,006,131,968.6312,657,788,827.12
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计890,320,952.137,500,547,034.085,656,393,363.533,986,161,434.83
经营活动现金流出小计1,504,009,741.857,211,310,931.285,480,229,696.293,767,330,478.48
经营活动产生的现金流量净额-613,688,789.72289,236,102.8176,163,667.24218,830,956.35
投资活动产生的现金流量:
投资活动现金流入小计813,042,541.725,345,256,380.82,643,845,819.31,294,842,286.96
投资活动现金流出小计843,294,992.015,982,259,480.974,118,725,860.542,657,025,967.73
投资活动产生的现金流量净额-30,252,450.29-637,003,100.17-1,474,880,041.24-1,362,183,680.77
筹资活动产生的现金流量:
筹资活动现金流入小计241,761,560.451,756,208,570.611,392,199,133.631,253,539,493.46
筹资活动现金流出小计337,609,378.232,410,844,094.491,506,012,944.111,099,931,735.21
筹资活动产生的现金流量净额-95,847,817.78-654,635,523.88-113,813,810.48153,607,758.25
汇率变动对现金及现金等价物的影响-1,835,325.48-534,546.4711,822.521,028,421.12
现金及现金等价物净增加额-741,624,383.27-1,002,937,067.65-1,411,818,361.96-988,716,545.05
期末现金及现金等价物余额389,362,960.851,130,987,344.12722,106,049.811,145,207,866.72
补充资料:
现金及现金等价物的净增加额--1,002,937,067.65--988,716,545.05
最新报告期:2026-05-05
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
中信建投袁全,刘若飞,沈兴熙,贺菊颖0.310.500.602026-05-05
华创证券郑辰,高初蕾0.320.470.542026-04-30
兴业证券孙媛媛,董晓洁,黄翰漾0.320.470.622026-04-21
中信建投袁全,刘若飞,沈兴熙,贺菊颖0.310.500.602026-04-08
中信建投袁全,刘若飞,沈兴熙,贺菊颖0.310.500.602026-04-06
TOP↑